Contemporary external validation of the Leibovich model for prediction of progression after radical surgery for clear cell renal cell carcinoma

References

• Cancer Registry of Norway. Cancer in Norway 2012 – cancer incidence, mortality, survival and prevalence. Oslo: Cancer Registry of Norway; 2014.
   Google Scholar
• Ljungberg B, Bensalah K, Bex A, Canfield S, Dabestani S, Hofmann F, et al. Guidelines on renal cell carcinoma. European Association of Urology. 2013. Available from http://www.uroweb.org/gls/pdf/10_Renal_Cell_Carcinoma_LR.pdf.
   Google Scholar
• Karakiewicz PI, Briganti A, Chun FK, Trinh QD, Perrotte P, Ficarra V, et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol 2007;25:1316–22.
   PubMed Web of Science ®Google Scholar
• Zisman A, Pantuck AJ, Dorey F, Said JW, Shvarts O, Quintana D, et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 2001;19:1649–57.
   PubMed Web of Science ®Google Scholar
• Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 2002;168:2395–400.
   PubMed Web of Science ®Google Scholar
• Karakiewicz PI, Suardi N, Capitanio U, Jeldres C, Ficarra V, Cindolo L, et al. A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma. Eur Urol 2009;55:287–95.
   PubMedGoogle Scholar
• Cindolo L, Chiodini P, Gallo C, Ficarra V, Schips L, Tostain J, et al. Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomy. Cancer 2008;113:65–71.
   PubMedGoogle Scholar
• Patard JJ, Leray E, Cindolo L, Ficarra V, Rodriguez A, De La Taille A, et al. Multi-institutional validation of a symptom based classification for renal cell carcinoma. J Urol 2004;172:858–62.
   PubMed Web of Science ®Google Scholar
• Cindolo L, Patard JJ, Chiodini P, Schips L, Ficarra V, Tostain J, et al. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study. Cancer 2005;104:1362–71.
   PubMed Web of Science ®Google Scholar
• Zigeuner R, Hutterer G, Chromecki T, Imamovic A, Kampel-Kettner K, Rehak P, et al. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology. Eur Urol 2010;57:102–9.
   PubMedGoogle Scholar
• Escudier B, Albiges L, Sonpavde G. Optimal management of metastatic renal cell carcinoma: current status. Drugs 2013;73:427–38.
   PubMed Web of Science ®Google Scholar
• Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 2003;97:1663–71.
   PubMed Web of Science ®Google Scholar
• Sorbellini M, Kattan MW, Snyder ME, Reuter V, Motzer R, Goetzl M, et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 2005;173:48–51.
   PubMed Web of Science ®Google Scholar
• Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 2001;166:63–7.
   PubMed Web of Science ®Google Scholar
• Pichler M, Hutterer GC, Chromecki TF, Jesche J, Kampel-Kettner K, Rehak P, et al. External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathology. J Urol 2011;186:1773–7.
   PubMed Web of Science ®Google Scholar
• Tan MH, Li H, Choong CV, Chia KS, Toh CK, Tang T, et al. The Karakiewicz nomogram is the most useful clinical predictor for survival outcomes in patients with localized renal cell carcinoma. Cancer 2011;117:5314–24.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83.
   PubMedGoogle Scholar
• Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655–63.
   PubMed Web of Science ®Google Scholar
• Royston P, Altman DG. External validation of a Cox prognostic model: principles and methods. BMC Med Res Methodol 2013;13:33.
   PubMed Web of Science ®Google Scholar
• Harrell FEJr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361–87.
   PubMed Web of Science ®Google Scholar
• Sun M, Trinh QD, Karakiewicz PI. Editorial comment. J Urol 2011;186:1777–8.
   PubMedGoogle Scholar
• Thorstenson A, Bergman M, Scherman-Plogell AH, Hosseinnia S, Ljungberg B, Adolfsson J, et al. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005–2010: a population-based study from the National Swedish Kidney Cancer Register. Scand J Urol 2014;48:231–8.
   PubMed Web of Science ®Google Scholar
• Sand KE, Hjelle KM, Rogde AJ, Gudbrandsdottir G, Bostad L, Beisland C. Incidentally detected renal cell carcinomas are highly associated with comorbidity and mortality unrelated to renal cell carcinoma. Scand J Urol 2013;47:462–71.
   PubMed Web of Science ®Google Scholar